Improvement of refractory impetiginized lesions after dupilumab treatment in children with atopic dermatitis.
- DOI
- 10.1111/pai.70478
- Published
- 2026 Sep
- Container
- Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/pai.70478,
title = {Improvement of refractory impetiginized lesions after dupilumab treatment in children with atopic dermatitis.},
author = {Fujita Y and Kaneko S and Kajitani S and Nakayama K and Yoshihara S and Miyamoto M and Kato M and Kitahara N and Shiraishi H and Yoshihara S},
year = {2026},
journal = {Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology},
doi = {10.1111/pai.70478},
url = {https://doi.org/10.1111/pai.70478}
}RIS
TY - JOUR TI - Improvement of refractory impetiginized lesions after dupilumab treatment in children with atopic dermatitis. AU - Fujita Y AU - Kaneko S AU - Kajitani S AU - Nakayama K AU - Yoshihara S AU - Miyamoto M AU - Kato M AU - Kitahara N AU - Shiraishi H AU - Yoshihara S PY - 2026 JO - Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology DO - 10.1111/pai.70478 UR - https://doi.org/10.1111/pai.70478 ER -
APA
Y, F., S, K., S, K., K, N., S, Y., M, M., M, K., N, K., H, S., & S, Y. (2026). Improvement of refractory impetiginized lesions after dupilumab treatment in children with atopic dermatitis.. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70478
Source records
- pubmed · retrieved 2026-09-25T18:50:27.609Z